Test.//.Bank:
Advanced.//.Pharmacology.//.for.//.Prescribers.//.1st.//.Edition.//.Luu.//.Kayingo.//.L
atest.//.Edition,.//.2024
, Table.//.of.//.Contents
Chapter.//. 1:.//. An.//. Introduction.//. to.//. Evidence-Based.//. Clinical.//. Practice.//. Guidelines ............................. 3
Chapter.//. 2:.//.Pharmacokinetics.//. /Chapter3:.//. Pharmacodynamics ............................................................ 13
Chapter4:.//. Pharmacogenetics.//. and.//.Pharmacogenomics .......................................................................... 25
Chapter.//. 5:.//.Pharmacology.//. Across.//.the.//.Life.//.Span .............................................................................. 30
Chapter.//. 6:.//.Drug-Therapy.//.Prescribing.//.in.//.Special.//.Populations......................................................... 36
Chapter.//. 7:.//.Drug.//.Development.//. and.//.Approval ................................................................................... 45
Chapter.//.8-Chapter.//.10:.//.Foundations.//.of.//.Prescription.//.Writing.//.Chapter.//.9:.//.ResponsibleControlled-
Substance.//.Prescribing.//.Chapter.//.10:.//.Antibiotic.//.Stewardship ................................................................ 51
Chapter.//. 11:.//. Applied.//.Calculations.//. for.//. Prescribing ............................................................................ 58
Chapter.//.12-:.//.Promoting.//.Adherence.//.With.//.Pharmacotherapy.//.II:.//.System-Specific.//.and.//.Patient-
Focused.//.Prescribing.//.Chapter.//.13:.//.Pharmacotherapy.//.for.//.Ear,.//.Nose,.//.Mouth,.//.andThroat.//.Conditions
.//./Chapter.//.14:.//.Pharmacotherapy.//.for.//. Eye.//.Conditions .......................................................................... 67
Chapter.//. 15:.//.Pharmacotherapy.//.for.//. Skin.//. Conditions .......................................................................... 74
Chapter.//. 16:.//.Pharmacotherapy.//. for.//. Neurologic.//. Conditions ............................................................... 81
Chapter.//. 17:.//. Pharmacotherapy.//.for.//. Cardiovascular.//. Conditions ........................................................ 94
Chapter.//. 18:.//. Pharmacotherapy.//. for.//. Respiratory.//.Conditions ............................................................ 106
Chapter.//.19:.//.Pharmacotherapy.//.for.//.Gastrointestinal.//.Conditions.//.and.//.Conditions.//.RequiringNutrition
al.//.Support ................................................................................................................................................. 117
Chapter.//. 20:.//.Pharmacotherapy.//.for.//. Genitourinary.//. Conditions......................................................... 128
Chapter.//. 21:.//.Pharmacotherapy.//.for.//. Renal,.//. Acid–Base,.//. Fluid,.//. and.//.Electrolyte.//.Disorders ........ 133
Chapter.//. 22:.//. Pharmacotherapy.//.for.//. Musculoskeletal.//. and.//. Rheumatologic.//. Conditions ................ 146
Chapter.//. 23:.//.Therapeutic.//. Applications. / / . of.//. Immunology.//. and.//. Vaccines...................................... 158
Chapter.//. 24:.//.Pharmacotherapy.//.for.//. Endocrine.//.Disorders ................................................................. 163
Chapter.//. 25:.//.Pharmacotherapy.//.for.//. Hematologic.//. Disorders ............................................................. 174
Chapter.//. 26:.//.Hematology/Oncology.//.and.//.Supportive.//. Care.//.for.//. the.//.Nononcologist .................... 190
Chapter. / / . 27:.//.Pharmacotherapy.//. Related.//. to.//.Women’s.//. Health.//. Conditions ................................... 196
Chapter.//. 28:.//. Pharmacotherapy.//. Related.//.to.//.Men’s.//. Health.//. Conditions ......................................... 211
Chapter. //. 29:.//.Pharmacotherapy.//. Related.//. to.//.Transgender. / / . Care ....................................................... 217
Chapter.//. 30:.//.Antimicrobial.//. Pharmacotherapy ...................................................................................... 224
Chapter.//. 31:.//.Antiretroviral.//. Pharmacotherapy ...................................................................................... 235
Chapter.//.32:.//.Psychopharmacology.//.and.//.Integrative.//.Health:.//.Combined.//.Treatment.//.ofPsychiatric.//.an
d.//.Neurocognitive.//.Conditions .................................................................................................................. 247
Chapter. / / . 33:.//.Pharmacotherapy.//.for.//. Pain.//.Management ..................................................................... 257
Chapter.//. 34:.//.Substance.//. Use.//.Disorder.//. III:.//.Health.//.Promotion.//.and.//.Maintenance ....................... 267
Chapter.//. 35:.//.Over-the-Counter.//. Medications ........................................................................................ 283
Chapter.//. 36:.//.Pharmacotherapy.//.for.//. Obesity ........................................................................................ 291
, Chapter.//.1:.//.An.//.Introduction.//. to.//.Evidence-Based.//.Clinical.//.Practice.//.Guidelines
MULTIPLE.//.CHOICE
• What.//.is.//.the.//.primary.//. purpose.//. of.//.the.//. nursing. / / . assessme
nt?
A. Identifying. / / . underlying. / / . pathologic. / / . conditions
B. Assisting. //. the.//. physician.//. in.//.identifying.//. medical.//. conditions
C. Determining.//. the.//. patients.//. mental.//.status
D. Exploring.//. patient.//. responses.//. to. / / . health.//. problems
ANS:.//.D
A.//.nursing.//.assessment.//.is.//.done.//.to.//.identify.//.the.//.patients.//.response.//.to./
/.health.//.problems..//.During.//.the.//.nursing.//.assessment.//.phase,.//.a.//.compreh
ensive.//.information.//.base.//.is.//.developed.//.through.//.a.//.physical.//.examinati
on,.//.nursing.//.history,.//.medication.//.history,.//.and.//.professional.//.observatio
n..//.Identifying.//.underlying.//.pathologic.//.conditions.//.and.//.assisting.//.the.//.p
hysician.//.in.//.identifying.//.medical.//.conditions.//.is.//.not.//.part.//.of.//.the.//.nursi
ng.//.process..//.Determining.//.the.//.patients. / / . mental.//.status. / / . is. / / . one.//.part. /
/ . of.//.the. / / . nursing. / / . assessment,. / / . but. / / . it. / / . is. / / . not.//.the.//.primary.//.purpo
se.
DIF:.//.Cognitive.//.Level:.//.Comprehensi
on.//.REF:.//.dm.//.36.//.OBJ:.//.1.//.|.//.3.//.TOP
:.//.Nursing.//.Process.//.Step:.//.Assessmen
t
MSC:.//.NCLEX.//. Client.//. Needs.//. Category:.//. Health.//. Promotion.//. and.//. Maintenance
• What.//.is.//.the.//. basis.//. of.//.the.//.NANDA.//.I. / / . taxonomy?
A. Functional.//. health.//.patterns
B. Human.//. response.//. patterns
C. Basic.//. human.//. needs
D. Pathophysiologic.//. needs
ANS:.//.B
The. / / . NANDA. / / . I. / / . taxonomy. / / . identifies. / / . human. / / . response. / / . p
atterns..//.Functional.//.components.//.of.//.health.//.patterns.//.are.//.limited.//.to.//.a
ctivity,.//.fluid.//.volume,.//.nutrition,.//.self.//.care,.//.and.//.sensory.//.perception..//
.Basic.//.human.//.needs.//.comprise.//.less.//.than.//.merely.//.health.//.patterns..//.P
athophysiologic.//.needs.//.are. / / . not.//.part.//.of.//.the.//.scope.//.of.//.NANDA.//.I
.
, DIF:.//.Cognitive.//.Level:.//.Knowledge.//.
REF:.//.pp..//.37-38.//.OBJ:.//.5.//.TOP:
Nursing.//.Process.//. Step:.//.Diagnosis
MSC:.//.NCLEX. //. Client.//. Needs.//. Category:.//. Physiological.//. Integrity
• Which.//.task.//. is.//.included.//. in.//.the.//.assessment.//.step.//. of.//.the.//. nursing. / / . process?
A. Establishing. //. patient. / / . goals/outcomes
B. Implementing.//. the. //. nursing.//. care.//. plan.//. (NCP)
C. Measuring.//. goal/outcome. / / . achievement
D. Collecting.//. and.//. communicating. / / . data
ANS:.//.D
Data.//.are.//.collected.//.and.//.communicated.//.in.//.the.//.assessment.//.phase.//.of.//.
the.//.nursing.//.process..//.Establishing.//.goals.//.is.//.the.//.function.//.of.//.planning
.
Implementing.//.the.//.NCP.//.is.//.the.//.function.//.of.//.implementation..//.Measuri
ng.//.outcome.//.achievement.//.is.//.the.//.function.//.of.//.evaluation.
DIF:.//.Cognitive.//.Level:.//.Comprehensi
on.//.REF:.//.dm.//.36.//.OBJ:.//.2.//.|.//.3.//.TOP
:.//.Nursing.//.Process.//.Step:.//.Assessmen
t
MSC:.//.NCLEX.//. Client.//. Needs.//. Category:.//. Health.//. Promotion.//. and.//. Maintenance
• Which.//.statement.//. regarding. //. nursing.//. diagnoses. / / . is. / / . accurate?
a. Nursing.//.diagnoses.//. remain.//.the.//.same.//. for.//. as.//. long.//.as.//. the.//.disease.//. is. /
/ . present.
b. Nursing.//. diagnoses.//. are.//. written.//. to.//. identify.//.disease.//.states.
c. Nursing.//. diagnoses.//. describe.//. patient.//. problems.//. that.//. nurses. / / . treat.
d. Nursing.//. diagnoses. / / . identify.//.causes.//. related.//. to.//. illness.
ANS:.//.C
Diagnostic.//.statements.//.identify.//.problems.//.a.//.nurse.//.is.//.independently.//.
able.//.to.//.treat.//.within.//.the.//.scope.//.of.//.professional.//.practice..//.Nursing.//.di
agnoses.//.vary.//.with.//.the.//.changing.//.condition.//.of.//.the.//.patient..//.The.//.res
ponse.//.patterns.//.are.//.unique.//.to.//.the.//.patient.//.and.//.are.//.not.//.disease.//.spec
ific..//.Nursing.//.diagnoses.//.describe.//.the.//.patients.//.human.//.response.//.patte
rn.
DIF:.//. Cognitive. //. Level:.//. Comprehension
Advanced.//.Pharmacology.//.for.//.Prescribers.//.1st.//.Edition.//.Luu.//.Kayingo.//.L
atest.//.Edition,.//.2024
, Table.//.of.//.Contents
Chapter.//. 1:.//. An.//. Introduction.//. to.//. Evidence-Based.//. Clinical.//. Practice.//. Guidelines ............................. 3
Chapter.//. 2:.//.Pharmacokinetics.//. /Chapter3:.//. Pharmacodynamics ............................................................ 13
Chapter4:.//. Pharmacogenetics.//. and.//.Pharmacogenomics .......................................................................... 25
Chapter.//. 5:.//.Pharmacology.//. Across.//.the.//.Life.//.Span .............................................................................. 30
Chapter.//. 6:.//.Drug-Therapy.//.Prescribing.//.in.//.Special.//.Populations......................................................... 36
Chapter.//. 7:.//.Drug.//.Development.//. and.//.Approval ................................................................................... 45
Chapter.//.8-Chapter.//.10:.//.Foundations.//.of.//.Prescription.//.Writing.//.Chapter.//.9:.//.ResponsibleControlled-
Substance.//.Prescribing.//.Chapter.//.10:.//.Antibiotic.//.Stewardship ................................................................ 51
Chapter.//. 11:.//. Applied.//.Calculations.//. for.//. Prescribing ............................................................................ 58
Chapter.//.12-:.//.Promoting.//.Adherence.//.With.//.Pharmacotherapy.//.II:.//.System-Specific.//.and.//.Patient-
Focused.//.Prescribing.//.Chapter.//.13:.//.Pharmacotherapy.//.for.//.Ear,.//.Nose,.//.Mouth,.//.andThroat.//.Conditions
.//./Chapter.//.14:.//.Pharmacotherapy.//.for.//. Eye.//.Conditions .......................................................................... 67
Chapter.//. 15:.//.Pharmacotherapy.//.for.//. Skin.//. Conditions .......................................................................... 74
Chapter.//. 16:.//.Pharmacotherapy.//. for.//. Neurologic.//. Conditions ............................................................... 81
Chapter.//. 17:.//. Pharmacotherapy.//.for.//. Cardiovascular.//. Conditions ........................................................ 94
Chapter.//. 18:.//. Pharmacotherapy.//. for.//. Respiratory.//.Conditions ............................................................ 106
Chapter.//.19:.//.Pharmacotherapy.//.for.//.Gastrointestinal.//.Conditions.//.and.//.Conditions.//.RequiringNutrition
al.//.Support ................................................................................................................................................. 117
Chapter.//. 20:.//.Pharmacotherapy.//.for.//. Genitourinary.//. Conditions......................................................... 128
Chapter.//. 21:.//.Pharmacotherapy.//.for.//. Renal,.//. Acid–Base,.//. Fluid,.//. and.//.Electrolyte.//.Disorders ........ 133
Chapter.//. 22:.//. Pharmacotherapy.//.for.//. Musculoskeletal.//. and.//. Rheumatologic.//. Conditions ................ 146
Chapter.//. 23:.//.Therapeutic.//. Applications. / / . of.//. Immunology.//. and.//. Vaccines...................................... 158
Chapter.//. 24:.//.Pharmacotherapy.//.for.//. Endocrine.//.Disorders ................................................................. 163
Chapter.//. 25:.//.Pharmacotherapy.//.for.//. Hematologic.//. Disorders ............................................................. 174
Chapter.//. 26:.//.Hematology/Oncology.//.and.//.Supportive.//. Care.//.for.//. the.//.Nononcologist .................... 190
Chapter. / / . 27:.//.Pharmacotherapy.//. Related.//. to.//.Women’s.//. Health.//. Conditions ................................... 196
Chapter.//. 28:.//. Pharmacotherapy.//. Related.//.to.//.Men’s.//. Health.//. Conditions ......................................... 211
Chapter. //. 29:.//.Pharmacotherapy.//. Related.//. to.//.Transgender. / / . Care ....................................................... 217
Chapter.//. 30:.//.Antimicrobial.//. Pharmacotherapy ...................................................................................... 224
Chapter.//. 31:.//.Antiretroviral.//. Pharmacotherapy ...................................................................................... 235
Chapter.//.32:.//.Psychopharmacology.//.and.//.Integrative.//.Health:.//.Combined.//.Treatment.//.ofPsychiatric.//.an
d.//.Neurocognitive.//.Conditions .................................................................................................................. 247
Chapter. / / . 33:.//.Pharmacotherapy.//.for.//. Pain.//.Management ..................................................................... 257
Chapter.//. 34:.//.Substance.//. Use.//.Disorder.//. III:.//.Health.//.Promotion.//.and.//.Maintenance ....................... 267
Chapter.//. 35:.//.Over-the-Counter.//. Medications ........................................................................................ 283
Chapter.//. 36:.//.Pharmacotherapy.//.for.//. Obesity ........................................................................................ 291
, Chapter.//.1:.//.An.//.Introduction.//. to.//.Evidence-Based.//.Clinical.//.Practice.//.Guidelines
MULTIPLE.//.CHOICE
• What.//.is.//.the.//.primary.//. purpose.//. of.//.the.//. nursing. / / . assessme
nt?
A. Identifying. / / . underlying. / / . pathologic. / / . conditions
B. Assisting. //. the.//. physician.//. in.//.identifying.//. medical.//. conditions
C. Determining.//. the.//. patients.//. mental.//.status
D. Exploring.//. patient.//. responses.//. to. / / . health.//. problems
ANS:.//.D
A.//.nursing.//.assessment.//.is.//.done.//.to.//.identify.//.the.//.patients.//.response.//.to./
/.health.//.problems..//.During.//.the.//.nursing.//.assessment.//.phase,.//.a.//.compreh
ensive.//.information.//.base.//.is.//.developed.//.through.//.a.//.physical.//.examinati
on,.//.nursing.//.history,.//.medication.//.history,.//.and.//.professional.//.observatio
n..//.Identifying.//.underlying.//.pathologic.//.conditions.//.and.//.assisting.//.the.//.p
hysician.//.in.//.identifying.//.medical.//.conditions.//.is.//.not.//.part.//.of.//.the.//.nursi
ng.//.process..//.Determining.//.the.//.patients. / / . mental.//.status. / / . is. / / . one.//.part. /
/ . of.//.the. / / . nursing. / / . assessment,. / / . but. / / . it. / / . is. / / . not.//.the.//.primary.//.purpo
se.
DIF:.//.Cognitive.//.Level:.//.Comprehensi
on.//.REF:.//.dm.//.36.//.OBJ:.//.1.//.|.//.3.//.TOP
:.//.Nursing.//.Process.//.Step:.//.Assessmen
t
MSC:.//.NCLEX.//. Client.//. Needs.//. Category:.//. Health.//. Promotion.//. and.//. Maintenance
• What.//.is.//.the.//. basis.//. of.//.the.//.NANDA.//.I. / / . taxonomy?
A. Functional.//. health.//.patterns
B. Human.//. response.//. patterns
C. Basic.//. human.//. needs
D. Pathophysiologic.//. needs
ANS:.//.B
The. / / . NANDA. / / . I. / / . taxonomy. / / . identifies. / / . human. / / . response. / / . p
atterns..//.Functional.//.components.//.of.//.health.//.patterns.//.are.//.limited.//.to.//.a
ctivity,.//.fluid.//.volume,.//.nutrition,.//.self.//.care,.//.and.//.sensory.//.perception..//
.Basic.//.human.//.needs.//.comprise.//.less.//.than.//.merely.//.health.//.patterns..//.P
athophysiologic.//.needs.//.are. / / . not.//.part.//.of.//.the.//.scope.//.of.//.NANDA.//.I
.
, DIF:.//.Cognitive.//.Level:.//.Knowledge.//.
REF:.//.pp..//.37-38.//.OBJ:.//.5.//.TOP:
Nursing.//.Process.//. Step:.//.Diagnosis
MSC:.//.NCLEX. //. Client.//. Needs.//. Category:.//. Physiological.//. Integrity
• Which.//.task.//. is.//.included.//. in.//.the.//.assessment.//.step.//. of.//.the.//. nursing. / / . process?
A. Establishing. //. patient. / / . goals/outcomes
B. Implementing.//. the. //. nursing.//. care.//. plan.//. (NCP)
C. Measuring.//. goal/outcome. / / . achievement
D. Collecting.//. and.//. communicating. / / . data
ANS:.//.D
Data.//.are.//.collected.//.and.//.communicated.//.in.//.the.//.assessment.//.phase.//.of.//.
the.//.nursing.//.process..//.Establishing.//.goals.//.is.//.the.//.function.//.of.//.planning
.
Implementing.//.the.//.NCP.//.is.//.the.//.function.//.of.//.implementation..//.Measuri
ng.//.outcome.//.achievement.//.is.//.the.//.function.//.of.//.evaluation.
DIF:.//.Cognitive.//.Level:.//.Comprehensi
on.//.REF:.//.dm.//.36.//.OBJ:.//.2.//.|.//.3.//.TOP
:.//.Nursing.//.Process.//.Step:.//.Assessmen
t
MSC:.//.NCLEX.//. Client.//. Needs.//. Category:.//. Health.//. Promotion.//. and.//. Maintenance
• Which.//.statement.//. regarding. //. nursing.//. diagnoses. / / . is. / / . accurate?
a. Nursing.//.diagnoses.//. remain.//.the.//.same.//. for.//. as.//. long.//.as.//. the.//.disease.//. is. /
/ . present.
b. Nursing.//. diagnoses.//. are.//. written.//. to.//. identify.//.disease.//.states.
c. Nursing.//. diagnoses.//. describe.//. patient.//. problems.//. that.//. nurses. / / . treat.
d. Nursing.//. diagnoses. / / . identify.//.causes.//. related.//. to.//. illness.
ANS:.//.C
Diagnostic.//.statements.//.identify.//.problems.//.a.//.nurse.//.is.//.independently.//.
able.//.to.//.treat.//.within.//.the.//.scope.//.of.//.professional.//.practice..//.Nursing.//.di
agnoses.//.vary.//.with.//.the.//.changing.//.condition.//.of.//.the.//.patient..//.The.//.res
ponse.//.patterns.//.are.//.unique.//.to.//.the.//.patient.//.and.//.are.//.not.//.disease.//.spec
ific..//.Nursing.//.diagnoses.//.describe.//.the.//.patients.//.human.//.response.//.patte
rn.
DIF:.//. Cognitive. //. Level:.//. Comprehension
